UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 155

Sortiert nach

Oxidative Stability and Its Effect on the Photoluminescence of Poly(Fluorene) Derivatives: End Group Effects

Chemistry of materials, 1999-04, Vol.11 (4), p.1083-1088

1999

Volltextzugriff (PDF)

High-Throughput Synthesis of Nanoscale Materials: Structural Optimization of Functionalized One-Step Star Polymers

Journal of the American Chemical Society, 2001-07, Vol.123 (26), p.6461-6462

2001

Volltextzugriff (PDF)

Correlation Between Patient-Reported Physical Limitation and Objective Physical Performance on the Repeated Chair Stand Test Among Patients with Non-Dialysis Dependent CKD and Metabolic Acidosis: PO1687

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.531-532

2020

Volltextzugriff (PDF)

Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension

The Lancet (British edition), 2019-08, Vol.394 (10196), p.396-406

2019

Volltextzugriff (PDF)

Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial

The Lancet (British edition), 2019-04, Vol.393 (10179), p.1417-1427

2019

Volltextzugriff (PDF)

Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease

The Journal of pharmacology and experimental therapeutics, 2020-12, Vol.375 (3), p.439

2020

Volltextzugriff (PDF)

Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD

Clinical journal of the American Society of Nephrology, 2018-01, Vol.13 (1), p.26-35

2018

Volltextzugriff (PDF)

Action of Veverimer on Gastrointestinal Acid Binding Is Not Affected by Omeprazole: PO2374

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.721-722

2020

Volltextzugriff (PDF)

Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis

Nephrology, dialysis, transplantation, 2023-05, Vol.38 (6), p.1448-1458

2023

Volltextzugriff (PDF)

No Adverse Effects of Veverimer on Volume Status or Blood Pressure in Patients with CKD and Metabolic Acidosis: PO2116

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.649-650

2020

Volltextzugriff (PDF)

Effects of Veverimer on Serum Bicarbonate and Physical Function in Women with CKD: A Subgroup Analysis from a Randomized Controlled Trial: PO2612

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.792-792

2020

Volltextzugriff (PDF)

Effects of Veverimer on Serum Bicarbonate and Physical Function in Elderly Patients with Metabolic Acidosis in CKD: PO1685

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.531-531

2020

Volltextzugriff (PDF)

Effects of Veverimer on Serum Bicarbonate and Physical Function in Patients with Diabetes and CKD: Subgroup Analysis from a Randomized Trial: PO1033

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.352-353

2020

Volltextzugriff (PDF)

Assessment of the Potential for Veverimer Drug-Drug Interactions

Drug metabolism and disposition, 2021-07, Vol.49 (7), p.490-500

2021

Volltextzugriff (PDF)

VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis

Journal of the American Society of Nephrology, 2024-03, Vol.35 (3), p.311

2024

Volltextzugriff (PDF)

P0001EFFECTS OF VEVERIMER ON SERUM BICARBONATE AND PHYSICAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND METABOLIC ACIDOSIS ARE INDEPENDENT OF ALBUMINURIA: SUBGROUP ANALYSES FROM A RANDOMIZED TRIAL

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation

Chemical communications (Cambridge, England), 2016-01, Vol.52 (76), p.11318-11334

2016

Volltextzugriff (PDF)

Aromatic Interactions by Molecular Tweezers and Clips in Chemical and Biological Systems

Accounts of chemical research, 2013-04, Vol.46 (4), p.967-978

2013

Volltextzugriff (PDF)

Evaluation of Veverimer Drug Interaction Potential: PO2373

Journal of the American Society of Nephrology, 2020-10, Vol.31 (10S), p.721-721

2020

Volltextzugriff (PDF)

P0009EVALUATION OF THE POTENTIAL FOR DRUG INTERACTIONS WITH VEVERIMER

Nephrology, dialysis, transplantation, 2020-06, Vol.35 (Supplement_3)

2020

Volltextzugriff (PDF)

Amyloid β‑Protein Assembly: The Effect of Molecular Tweezers CLR01 and CLR03

The journal of physical chemistry. B, 2015-04, Vol.119 (14), p.4831-4841

2015

Volltextzugriff (PDF)

Molecular tweezers modulate 14-3-3 protein-protein interactions

Nature chemistry, 2013-03, Vol.5 (3), p.234

2013

Volltextzugriff (PDF)

Molecular Tweezers with Additional Recognition Sites

Chemistry : a European journal, 2018-08, Vol.24 (44), p.11332-11343

2018

Volltextzugriff (PDF)

The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease

Molecular therapy, 2020-04, Vol.28 (4), p.1167-1176

2020

Volltextzugriff (PDF)

Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid Proteins

Journal of the American Chemical Society, 2011-10, Vol.133 (42), p.16958-16969

2011

Volltextzugriff (PDF)

1 – 25 von 155

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(150)

Publikationsform

Artikel
(154)
Buchkapitel
(1)

Sprache

Englisch
(107)
Deutsch
(52)
Japanisch
(18)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Physical Sciences
(50)
Chemistry
(49)
Life Sciences & Biomedicine
(30)
Chemistry, Multidisciplinary
(27)
Animals
(21)
Humans
(21)
Organic Chemistry
(15)
Chemistry, Organic
(14)
Organophosphates - Pharmacology
(14)
Bridged-Ring Compounds - Pharmacology
(12)
Male
(11)
Models, Molecular
(11)
Binding Sites
(10)
Biochemistry & Molecular Biology
(10)
Molecular Tweezers
(10)
Exact Sciences And Technology
(9)
Mice
(9)
Amyloid
(8)
Pharmacology & Pharmacy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Oxidative Stability and Its Effect on the Photoluminescence of Poly(Fluorene) Derivatives: End Group Effects

High-Throughput Synthesis of Nanoscale Materials: Structural Optimization of Functionalized One-Step Star Polymers

Correlation Between Patient-Reported Physical Limitation and Objective Physical Performance on the Repeated Chair Stand Test Among Patients with Non-Dialysis Dependent CKD and Metabolic Acidosis: PO1687

Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension

Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial

Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease

Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD

Action of Veverimer on Gastrointestinal Acid Binding Is Not Affected by Omeprazole: PO2374

Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis

No Adverse Effects of Veverimer on Volume Status or Blood Pressure in Patients with CKD and Metabolic Acidosis: PO2116

Effects of Veverimer on Serum Bicarbonate and Physical Function in Women with CKD: A Subgroup Analysis from a Randomized Controlled Trial: PO2612

Effects of Veverimer on Serum Bicarbonate and Physical Function in Elderly Patients with Metabolic Acidosis in CKD: PO1685

Effects of Veverimer on Serum Bicarbonate and Physical Function in Patients with Diabetes and CKD: Subgroup Analysis from a Randomized Trial: PO1033

Assessment of the Potential for Veverimer Drug-Drug Interactions

VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis

P0001EFFECTS OF VEVERIMER ON SERUM BICARBONATE AND PHYSICAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND METABOLIC ACIDOSIS ARE INDEPENDENT OF ALBUMINURIA: SUBGROUP ANALYSES FROM A RANDOMIZED TRIAL

Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation

Aromatic Interactions by Molecular Tweezers and Clips in Chemical and Biological Systems

Evaluation of Veverimer Drug Interaction Potential: PO2373

P0009EVALUATION OF THE POTENTIAL FOR DRUG INTERACTIONS WITH VEVERIMER

Amyloid β‑Protein Assembly: The Effect of Molecular Tweezers CLR01 and CLR03

Molecular tweezers modulate 14-3-3 protein-protein interactions

Molecular Tweezers with Additional Recognition Sites

The Amyloid Inhibitor CLR01 Relieves Autophagy and Ameliorates Neuropathology in a Severe Lysosomal Storage Disease

Lysine-Specific Molecular Tweezers Are Broad-Spectrum Inhibitors of Assembly and Toxicity of Amyloid Proteins

Suchergebnisse filtern